Compounds > sansert
Page last updated: 2024-10-31

sansert and Craniofacial Pain Syndromes

sansert has been researched along with Craniofacial Pain Syndromes in 1 studies

1-methyllysergic acid butanolamide: RN given refers to parent cpd(8beta)-isomer

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CROWTHER, DL1

Other Studies

1 other study available for sansert and Craniofacial Pain Syndromes

ArticleYear
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    Medicina experimentalis : International journal of experimental medicine, 1964, Volume: 10

    Topics: Analgesics; Ergot Alkaloids; Facial Neuralgia; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Me

1964